Pneumonia and its sequelae, acute lung injury, present unique challenges for pulmonary
and critical care healthcare professionals, and these challenges have recently garnered …

Background Adult respiratory syncytial virus (RSV) vaccines are in the late stages of
development. A comprehensive synthesis of adult RSV burden is needed to inform public …

Background Whether the antiinflammatory and immunomodulatory effects of glucocorticoids
may decrease mortality among patients with severe community-acquired pneumonia is …

This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

Background The etiology of community-acquired pneumonia (CAP) has evolved since the
beginning of the antibiotic era. Recent guidelines encourage immediate empiric antibiotic …

Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

The ability to provide timely identification of the causative agents of lower respiratory tract
infections can promote better patient outcomes and support antimicrobial stewardship …

Current standard protocols used in the clinic for diagnosing COVID-19 include molecular or
antigen tests, generally complemented by a plain chest X-Ray. The combined analysis aims …